- GBI & PARTNERS
- Brazil steps up efforts against TB
Brazil steps up efforts against TB
Brazil’s Ministry of Health (MoH) this week announced that an effervescent tablet that combines all drugs needed for the treatment of tuberculosis (TB) will be adopted in 2020. The product will include a rifampin + isoniazid + pyrazinamide combination for the intensive phase, and rifampin + isoniazid for the maintenance phase. It is designed to improve treatment adherence, especially in children.
The announcement comes as the MoH readies to preside the three following years over the United Nations (UN)’s Stop TB Partnership, which encompasses almost 1,700 institutions in over 100 nations, and aims at eliminating the disease worldwide. At the same time, Brazil will head the BRICS group’s Tuberculosis Research Network, where the country has committed to invest BRL 16 million (USD 3.9 million) in the promotion of new therapies, diagnosis methods, and treatment access.